AstraZeneca
AstraZeneca, a global biopharmaceutical company, is headquartered in the United States and operates extensively across Europe, Asia, and other regions. Founded in 1999 through the merger of Astra AB and Zeneca Group PLC, the company has since established itself as a leader in the pharmaceutical industry, focusing on the discovery, development, and commercialisation of innovative medicines. Specialising in areas such as oncology, cardiovascular, renal, and respiratory diseases, AstraZeneca is renowned for its commitment to research and development. Its core products, including the widely recognised cancer treatment Tagrisso and the COVID-19 vaccine Vaxzevria, exemplify the company's dedication to addressing unmet medical needs. With a strong market position and numerous accolades, AstraZeneca continues to make significant contributions to global health, driven by a mission to improve patient outcomes worldwide.
DitchCarbon Score
How does AstraZeneca's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AstraZeneca's score of 3 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AstraZeneca's reported carbon emissions
AstraZeneca, headquartered in the US, is committed to addressing climate change through various initiatives, although specific emissions data for recent years is not available. The company has not disclosed any absolute carbon emissions figures, including Scope 1, 2, or 3 emissions, nor has it outlined specific reduction targets or achievements. Despite the absence of detailed emissions data, AstraZeneca's commitment to sustainability is evident in its broader climate initiatives. The company is likely to be aligning with industry standards and best practices to mitigate its environmental impact. As the pharmaceutical sector increasingly focuses on reducing carbon footprints, AstraZeneca's future commitments and strategies will be crucial in contributing to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AstraZeneca is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
